Richard Dilorio
Chief Executive Officer presso INFUSYSTEM HOLDINGS, INC.
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Mr. Richard A.
Dilorio is an Independent Director at Dignitana AB and a Chief Executive Officer & Director at InfuSystem Holdings, Inc. He is on the Board of Directors at Dignitana AB and InfuSystem Holdings, Inc. Mr. Dilorio was previously employed as an Executive Vice President-Oncology Sales by InfuSystem, Inc. He received his undergraduate degree from Boston College.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
21/08/2023 | 424 848 ( 2.01% ) | 4 M $ | 31/03/2024 |
Posizioni attive di Richard Dilorio
Società | Posizione | Inizio |
---|---|---|
INFUSYSTEM HOLDINGS, INC. | Chief Executive Officer | 15/11/2017 |
DIGNITANA AB | Director/Board Member | 01/01/2020 |
Precedenti posizioni note di Richard Dilorio
Società | Posizione | Fine |
---|---|---|
InfuSystem, Inc.
InfuSystem, Inc. Medical SpecialtiesHealth Technology Part of InfuSystem Holdings, Inc., InfuSystem, Inc. is a private company that manufactures external ambulatory infusion pumps. The company is based in Madison Heights, MI. InfuSystem was acquired by HAPC, Inc. from I-Flow Corp. on October 26, 2007 for $112 million. | Corporate Officer/Principal | 01/11/2016 |
Formazione di Richard Dilorio
Boston College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
INFUSYSTEM HOLDINGS, INC. | Commercial Services |
DIGNITANA AB | Health Technology |
Aziende private | 1 |
---|---|
InfuSystem, Inc.
InfuSystem, Inc. Medical SpecialtiesHealth Technology Part of InfuSystem Holdings, Inc., InfuSystem, Inc. is a private company that manufactures external ambulatory infusion pumps. The company is based in Madison Heights, MI. InfuSystem was acquired by HAPC, Inc. from I-Flow Corp. on October 26, 2007 for $112 million. | Health Technology |
- Borsa valori
- Insiders
- Richard Dilorio